Published in J Diabetes Investig on December 15, 2016
Prevalence and Predictors of Home Use of Glucometers in Diabetic Patients. Cureus (2017) 0.75
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA (2006) 11.78
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care (1999) 9.16
International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig (2012) 7.33
Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med (2001) 6.15
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care (2002) 3.96
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care (1998) 3.94
Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes (2005) 3.84
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia (1996) 3.62
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia (1999) 3.60
Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med (2004) 3.12
Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab (2005) 2.88
Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care (2009) 2.50
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia (2004) 2.25
Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia (2001) 2.12
Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care (1997) 2.01
Postprandial glucose regulation and diabetic complications. Arch Intern Med (2004) 1.97
Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia (2002) 1.63
Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care (2004) 1.53
Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care (2011) 1.53
Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes (1987) 1.45
Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem (2012) 1.43
Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev (2009) 1.27
Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study. Diabetes Care (2012) 0.98
Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemia. Diabetes Care (2011) 0.96
Post-prandial glucose and diabetic complications: systematic review of observational studies. Acta Diabetol (2011) 0.93
Daytime variability of postprandial glucose tolerance and pancreatic B-cell function using 12-h profiles in persons with Type 2 diabetes. Diabet Med (2010) 0.89
Association between HbA1c variability and mortality in patients with type 2 diabetes. J Diabetes Complications (2014) 0.85
The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes. BMJ Open Diabetes Res Care (2015) 0.81
Genome-wide assessment of oxidatively generated DNA damage. Free Radic Res (2012) 0.79
Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes Mellitus. J Diabetes Investig (2017) 0.77
Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells. Cardiovasc Diabetol (2016) 0.77
Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan. Patient Prefer Adherence (2015) 0.97
Association between HbA1c variability and mortality in patients with type 2 diabetes. J Diabetes Complications (2014) 0.85
Validity and reliability of the Japanese version of the Newest Vital Sign: a preliminary study. PLoS One (2014) 0.85
Relationships between the risk of cardiovascular disease in type 2 diabetes patients and both visit-to-visit variability and time-to-effect differences in blood pressure. J Diabetes Complications (2015) 0.77
Relationship between individual characteristics, neighbourhood contexts and help-seeking intentions for mental illness. BMJ Open (2015) 0.76
Temporal Changes in Post-Infectious Glomerulonephritis in Japan (1976-2009). PLoS One (2016) 0.75
Predictive ability of visit-to-visit variability in HbA1c and systolic blood pressure for the development of microalbuminuria and retinopathy in people with type 2 diabetes. Diabetes Res Clin Pract (2017) 0.75
Adaptation of the European Commission-recommended user testing method to patient medication information leaflets in Japan. Drug Healthc Patient Saf (2017) 0.75
Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes. FASEB J (2017) 0.75
Time-to-effect relationships between systolic blood pressure and the risks of nephropathy and retinopathy in patients with type 2 diabetes. J Diabetes Complications (2014) 0.75
Polyuria-associated hydronephrosis induced by xenobiotic chemical exposure in mice. Am J Physiol Renal Physiol (2016) 0.75